Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Psychophysiol. 2013 Jun;88(3):349-52. doi: 10.1016/j.ijpsycho.2012.09.014. Epub 2012 Oct 6.

Catecholamine predictors of complicated grief treatment outcomes.

Author information

1
Department of Psychology, University of Arizona, Tucson, AZ 85721, USA. mfoconnor@email.arizona.edu

Abstract

Could sympathetic hyperarousal limit treatment success in complicated grief? The present study investigated persons with complicated grief, a chronic condition with distinct symptoms including persistent intense yearning and longing for the person who died, avoidance of reminders that the person is gone, deep relentless sadness, self-blame, bitterness, or anger in connection with the death, and an inability to gain satisfaction or joy through engaging in meaningful activities or relationships with significant others. Length of bereavement did not correlate with complicated grief scores. Catecholamines (i.e., epinephrine, norepinephrine, dopamine) in plasma were assessed pre- and post-psychotherapeutic treatment. Participants with the highest levels of epinephrine at pre-treatment had the highest levels of complicated grief symptoms at post-treatment, accounting for baseline levels of symptoms. This predictive relationship was not seen for depressive symptoms. The present study supports the hypothesis that catecholamine levels are affected by bereavement, and in turn, can affect the ability of those with complicated grief to benefit from psychotherapy.

PMID:
23044089
PMCID:
PMC3664660
DOI:
10.1016/j.ijpsycho.2012.09.014
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center